Ptc Therapeutics (PTCT) Other Non Operating Income (2016 - 2025)
Historic Other Non Operating Income for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $6.5 million.
- Ptc Therapeutics' Other Non Operating Income rose 44732.91% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 10252.61%. This contributed to the annual value of $6.5 million for FY2024, which is 10475.73% up from last year.
- Ptc Therapeutics' Other Non Operating Income amounted to $6.5 million in Q3 2025, which was up 44732.91% from -$5.7 million recorded in Q2 2025.
- Over the past 5 years, Ptc Therapeutics' Other Non Operating Income peaked at $35.1 million during Q4 2022, and registered a low of -$128.7 million during Q4 2023.
- Its 5-year average for Other Non Operating Income is -$12.8 million, with a median of -$5.7 million in 2025.
- Its Other Non Operating Income has fluctuated over the past 5 years, first tumbled by 118381.7% in 2022, then skyrocketed by 44732.91% in 2025.
- Quarter analysis of 5 years shows Ptc Therapeutics' Other Non Operating Income stood at -$31.4 million in 2021, then surged by 212.02% to $35.1 million in 2022, then crashed by 466.24% to -$128.7 million in 2023, then soared by 106.88% to $8.8 million in 2024, then decreased by 26.53% to $6.5 million in 2025.
- Its Other Non Operating Income was $6.5 million in Q3 2025, compared to -$5.7 million in Q2 2025 and -$6.3 million in Q1 2025.